Nerandomilast in IPF and PPF: A New Option On the Horizon

Join us for this webinar as respirologist Dr. Shane Shapera discusses the current state of diagnosis and treatment for idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), the challenges and benefits of existing therapies, and the potential of Nerandomilast to revolutionize patient care.

Sign up for the webinar below.
Live stream will start at 2PM EDT on September 4, 2025.